Michael Z. Liao

889 total citations
24 papers, 384 citations indexed

About

Michael Z. Liao is a scholar working on Oncology, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Michael Z. Liao has authored 24 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Michael Z. Liao's work include CAR-T cell therapy research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Pregnancy and preeclampsia studies (4 papers). Michael Z. Liao is often cited by papers focused on CAR-T cell therapy research (6 papers), HER2/EGFR in Cancer Research (5 papers) and Pregnancy and preeclampsia studies (4 papers). Michael Z. Liao collaborates with scholars based in United States, Belgium and Germany. Michael Z. Liao's co-authors include Qingcheng Mao, Chunying Gao, Naveen K. Neradugomma, Kenneth E. Thummel, Dale Miles, Chunze Li, Zhican Wang, Yvonne S. Lin, Dan Lu and Matts Kågedal and has published in prestigious journals such as Advanced Drug Delivery Reviews, Clinical Cancer Research and Biochemical Pharmacology.

In The Last Decade

Michael Z. Liao

24 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Z. Liao United States 12 180 84 70 66 56 24 384
Malvika Solanki United States 10 53 0.3× 62 0.7× 71 1.0× 20 0.3× 25 0.4× 28 331
A. Wolf Germany 13 59 0.3× 43 0.5× 83 1.2× 65 1.0× 71 1.3× 47 500
SE Hankinson United States 6 74 0.4× 56 0.7× 204 2.9× 216 3.3× 17 0.3× 8 695
D.S. Allen United Kingdom 14 225 1.3× 78 0.9× 69 1.0× 15 0.2× 11 0.2× 19 485
Linda Lewis United States 7 124 0.7× 39 0.5× 124 1.8× 14 0.2× 44 0.8× 8 415
Bahadır Batar Türkiye 17 132 0.7× 66 0.8× 422 6.0× 50 0.8× 55 1.0× 43 677
Galina Lurie United States 18 341 1.9× 27 0.3× 79 1.1× 47 0.7× 37 0.7× 23 827
María Santos Spain 11 113 0.6× 39 0.5× 219 3.1× 32 0.5× 10 0.2× 20 500
Jamie L. Resnik United States 10 134 0.7× 82 1.0× 358 5.1× 12 0.2× 25 0.4× 13 688
Xiaohong Xue China 10 67 0.4× 29 0.3× 140 2.0× 11 0.2× 15 0.3× 24 350

Countries citing papers authored by Michael Z. Liao

Since Specialization
Citations

This map shows the geographic impact of Michael Z. Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Z. Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Z. Liao more than expected).

Fields of papers citing papers by Michael Z. Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Z. Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Z. Liao. The network helps show where Michael Z. Liao may publish in the future.

Co-authorship network of co-authors of Michael Z. Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Z. Liao. A scholar is included among the top collaborators of Michael Z. Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Z. Liao. Michael Z. Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xin, Chunying Gao, Sibylle Heidelberger, et al.. (2024). Efflux transporters in drug disposition during pregnancy. Drug Metabolism and Disposition. 53(1). 100022–100022. 3 indexed citations
2.
Hamed, Salaheldin S., et al.. (2024). Patient, industry, and regulatory perspective on antibody‐drug conjugates dose optimization. Clinical and Translational Science. 17(3). e13759–e13759. 3 indexed citations
3.
Liao, Michael Z., Dan Lu, Tong Lu, et al.. (2024). Clinical pharmacology strategies to accelerate the development of polatuzumab vedotin and summary of key findings. Advanced Drug Delivery Reviews. 207. 115193–115193. 2 indexed citations
4.
Turner, David C., et al.. (2023). Pharmacokinetics of biologics in gastric cancer. Clinical and Translational Science. 16(4). 564–574. 4 indexed citations
5.
Liao, Michael Z., Rong Deng, Leonid Gibiansky, et al.. (2023). Ethnic sensitivity assessment: Polatuzumab vedotin pharmacokinetics in Asian and non‐Asian patients with previously untreated diffuse large B‐cell lymphoma in POLARIX. Clinical and Translational Science. 16(12). 2744–2755. 3 indexed citations
6.
Mody, Hardik, K. OGASAWARA, Xu Zhu, et al.. (2023). Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective. Clinical Pharmacology & Therapeutics. 114(3). 530–557. 18 indexed citations
7.
Liao, Michael Z., et al.. (2022). Clinical Pharmacology Considerations on Recombinant Adeno‐Associated Virus–Based Gene Therapy. The Journal of Clinical Pharmacology. 62(S2). S79–S94. 18 indexed citations
8.
Deegen, Petra, Oliver S. Thomas, Olivier Nolan-Stevaux, et al.. (2021). The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer. Clinical Cancer Research. 27(10). 2928–2937. 58 indexed citations
9.
Huang, Weize, Junyi Li, Michael Z. Liao, et al.. (2021). Clinical Pharmacology Perspectives for Adoptive Cell Therapies in Oncology. Clinical Pharmacology & Therapeutics. 112(5). 968–981. 16 indexed citations
10.
Liao, Michael Z., Hans Prenen, Sandeep Dutta, & Vijay Upreti. (2021). The impact of hepatic and renal function on panitumumab exposures in patients with metastatic RAS wild-type colorectal cancer. Cancer Chemotherapy and Pharmacology. 88(4). 665–672. 1 indexed citations
11.
Feng, Tom, et al.. (2020). Randomised comparison of techniques for control of the dorsal venous complex during robot‐assisted laparoscopic radical prostatectomy. British Journal of Urology. 126(5). 586–594. 12 indexed citations
12.
Liao, Michael Z., et al.. (2020). <p>Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not</p>. Clinical Pharmacology Advances and Applications. Volume 12. 109–114. 1 indexed citations
13.
Liao, Michael Z., Mahmoud Ahmed, Shannon Clark, et al.. (2020). Effects of Pregnancy on the Pharmacokinetics of Metformin. Drug Metabolism and Disposition. 48(4). 264–271. 33 indexed citations
14.
Gao, Chunying, et al.. (2018). Hepatic Transport of 25-Hydroxyvitamin D3 Conjugates: A Mechanism of 25-Hydroxyvitamin D3 Delivery to the Intestinal Tract. Drug Metabolism and Disposition. 46(5). 581–591. 26 indexed citations
15.
Neradugomma, Naveen K., et al.. (2018). Marijuana use differentially affects cannabinoid receptor expression in early gestational human endometrium and placenta. Placenta. 66. 36–39. 6 indexed citations
16.
17.
Liao, Michael Z., Chunying Gao, Laura M. Shireman, et al.. (2017). P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine. Pharmacological Research. 119. 61–71. 24 indexed citations
18.
Liao, Michael Z., Chunying Gao, Brian Phillips, et al.. (2017). Pregnancy Increases Norbuprenorphine Clearance in Mice by Induction of Hepatic Glucuronidation. Drug Metabolism and Disposition. 46(2). 100–108. 10 indexed citations
19.
Neradugomma, Naveen K., Michael Z. Liao, & Qingcheng Mao. (2016). Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts. Molecular Pharmacology. 91(3). 237–249. 27 indexed citations
20.
Zheng, Xi, Zhican Wang, Michael Z. Liao, et al.. (2012). Human PXR-mediated induction of intestinal CYP3A4 attenuates 1α,25-dihydroxyvitamin D3 function in human colon adenocarcinoma LS180 cells. Biochemical Pharmacology. 84(3). 391–401. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malvika Solanki Breakdown of academic impact, for papers by A. Wolf Breakdown of academic impact, for papers by SE Hankinson Breakdown of academic impact, for papers by D.S. Allen Breakdown of academic impact, for papers by Linda Lewis Breakdown of academic impact, for papers by Bahadır Batar Breakdown of academic impact, for papers by Galina Lurie Breakdown of academic impact, for papers by María Santos Breakdown of academic impact, for papers by Jamie L. Resnik Breakdown of academic impact, for papers by Xiaohong Xue
Rankless by CCL
2026